Cargando…
Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine
Seroconversion panels are an important tool for investigating antibody responses in acute and chronic phases of disease and development of serological assays for viral diseases including COVID-19. Globally it is anticipated that vaccines against SARS-CoV-2 will facilitate control of the current pand...
Autores principales: | Belda, Francisco, Mora, Oscar, Lopez Martinez, Monica, Torres, Nerea, Vivanco, Ana, Christie, Rebecca, Crowley, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989688/ https://www.ncbi.nlm.nih.gov/pubmed/35443917 http://dx.doi.org/10.1016/j.vaccine.2022.04.006 |
Ejemplares similares
-
Available COVID-19 serial seroconversion panel for validation of SARS-CoV-2 antibody assays.
por: Belda, Francisco, et al.
Publicado: (2021) -
Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine
por: MITRI, Fouad, et al.
Publicado: (2021) -
Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine
por: Hoshina, Yoji, et al.
Publicado: (2022) -
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
por: Haq, Hannah N., et al.
Publicado: (2022) -
Sub-cutaneous Pfizer/BioNTech COVID-19 vaccine administration results in seroconversion among young adults
por: Friedensohn, Limor, et al.
Publicado: (2021)